The list prices for nearly two dozen drugs increased by at least 200 percent since January 2017, according to an analysis by Pharmacy Benefits Consultants.
For the analysis, Pharmacy Benefits Consultants examined changes in average wholesale drug prices between January 2017 and March 2018
The topical skin cream SynerDerm topped the list of medications with the highest price hikes. Phlight Pharma, the drug's manufacturer, boosted the cream's list price by 1,468 percent over the 14-month period. The second highest price hike occurred for Burke Therapeutics' emulsion skin spray Entty, which saw a 646 percent increase in its list price over the same time period.
In total, 20 drugs had price increases of 200 percent or more, and another 19 drugs had price hikes of 100 percent or more.
The analysis comes just days after President Donald Trump reaffirmed his pledge to lower prescription drug prices at a March 19 speech in Manchester, N.H. The president said his administration would introduce new steps to address the issue next month.
More articles on supply chain:
Walgreens to pay $5.5M to resolve allegations of overcharging for prescription drugs
Trump: Stay tuned for federal action on high drug price
Survey: Top healthcare supply chain priorities in 2018